重庆健能医药开发有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
8
NMPA:8
Drug Approvals
Magnesium Sulfate, Sodium Sulfate and Potassium Sulfate Concentrate Oral Solution
- Product Name
- 硫酸镁钠钾口服用浓溶液
- Approval Number
- 国药准字H20249699
- Approval Date
- Dec 6, 2024
NMPA
Sodium Valproate Oral Solution
- Product Name
- 丙戊酸钠口服溶液
- Approval Number
- 国药准字H20244966
- Approval Date
- Sep 26, 2024
NMPA
Sodium Valproate Oral Solution
- Product Name
- 丙戊酸钠口服溶液
- Approval Number
- 国药准字H20244965
- Approval Date
- Sep 26, 2024
NMPA
Polyethylene Glycol Electrolytes Powder(III)
- Product Name
- 复方聚乙二醇电解质散(Ⅲ)
- Approval Number
- 国药准字H20244333
- Approval Date
- Jun 28, 2024
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20234664
- Approval Date
- Dec 19, 2023
NMPA
Ambroxol Hydrochloride Oral Solution
- Product Name
- 盐酸氨溴索口服溶液
- Approval Number
- 国药准字H20233009
- Approval Date
- Jan 3, 2023
NMPA
Clinical Trials
No trials found
News
No news found